Invention Publication
![THIAZOLO[5,4-B]PYRIDINE MALT-1 INHIBITORS](/docs/US/2023-10-05/US20230312601A1/abs.jpg.600x600.jpg)
- Patent Title: THIAZOLO[5,4-B]PYRIDINE MALT-1 INHIBITORS
-
Application No.: US18192810Application Date: 2023-03-30
-
Publication No.: US20230312601A1Publication Date: 2023-10-05
- Inventor: Daniel Cohen , Jane Gong , Tarun Jain , Puneet Kumar , Dachun Liu , Anthony Mastracchio , Mark Mills , Andrew William Phillips , John K. Pratt , Sreenivas Punna , Jennifer Ann Stockwell , Le Wang , Yiyun Yu
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: C07D513/04
- IPC: C07D513/04 ; A61P35/00
![THIAZOLO[5,4-B]PYRIDINE MALT-1 INHIBITORS](/abs-image/US/2023/10/05/US20230312601A1/abs.jpg.150x150.jpg)
Abstract:
The present disclosure provides for compounds of the general Formula (I)
wherein R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and Ring A have any of the values defined in the specification, and pharmaceutically acceptable salts thereof.
wherein R1a, R1b, R2, R3, R4, R5, R6, R7, R8, and Ring A have any of the values defined in the specification, and pharmaceutically acceptable salts thereof.
Public/Granted literature
- US11993613B2 Thiazolo[5,4-b]pyridine MALT-1 inhibitors Public/Granted day:2024-05-28
Information query
